BMRN logo

BioMarin Pharmaceutical Inc. (BMRN) Gross profit

Annual gross profit:

$2.22B+$373.37M(+20.27%)
December 31, 2024

Summary

  • As of today (September 13, 2025), BMRN annual gross profit is $2.22 billion, with the most recent change of +$373.37 million (+20.27%) on December 31, 2024.
  • During the last 3 years, BMRN annual gross profit has risen by +$902.08 million (+68.67%).
  • BMRN annual gross profit is now at all-time high.

Performance

BMRN Gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNincome statement metrics

quarterly gross profit:

$672.54M+$91.50M(+15.75%)
June 30, 2025

Summary

  • As of today (September 13, 2025), BMRN quarterly gross profit is $672.54 million, with the most recent change of +$91.50 million (+15.75%) on June 30, 2025.
  • Over the past year, BMRN quarterly gross profit has increased by +$108.64 million (+19.27%).
  • BMRN quarterly gross profit is now at all-time high.

Performance

BMRN quarterly gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNincome statement metrics

TTM gross profit:

$2.39B+$108.64M(+4.75%)
June 30, 2025

Summary

  • As of today (September 13, 2025), BMRN TTM gross profit is $2.39 billion, with the most recent change of +$108.64 million (+4.75%) on June 30, 2025.
  • Over the past year, BMRN TTM gross profit has increased by +$379.82 million (+18.85%).
  • BMRN TTM gross profit is now at all-time high.

Performance

BMRN TTM gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNincome statement metrics

Gross profit Formula

Gross Profit = Revenue − Cost Of Goods Sold

BMRN Gross profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+20.3%+19.3%+18.9%
3 y3 years+68.7%+72.8%+74.9%
5 y5 years+74.0%+118.5%+76.9%

BMRN Gross profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+68.7%at high+87.9%at high+74.9%
5 y5-yearat high+76.4%at high+151.8%at high+93.5%
alltimeall timeat high>+9999.0%at high>+9999.0%at high>+9999.0%

BMRN Gross profit History

DateAnnualQuarterlyTTM
Jun 2025
-
$672.54M(+15.7%)
$2.39B(+4.8%)
Mar 2025
-
$581.04M(-1.9%)
$2.29B(+3.2%)
Dec 2024
$2.22B(+20.3%)
$592.43M(+7.9%)
$2.22B(+4.6%)
Sep 2024
-
$548.91M(-2.7%)
$2.12B(+5.1%)
Jun 2024
-
$563.90M(+10.5%)
$2.02B(+5.9%)
Mar 2024
-
$510.47M(+3.1%)
$1.90B(+3.2%)
Dec 2023
$1.84B(+22.7%)
$495.19M(+11.1%)
$1.84B(+7.1%)
Sep 2023
-
$445.54M(-1.2%)
$1.72B(+5.4%)
Jun 2023
-
$450.92M(+0.0%)
$1.63B(+3.9%)
Mar 2023
-
$450.70M(+20.9%)
$1.57B(+4.6%)
Dec 2022
$1.50B(+14.3%)
$372.83M(+4.2%)
$1.50B(+4.4%)
Sep 2022
-
$357.88M(-8.0%)
$1.44B(+5.0%)
Jun 2022
-
$389.14M(+2.1%)
$1.37B(+2.0%)
Mar 2022
-
$381.22M(+23.3%)
$1.34B(+2.1%)
Dec 2021
$1.31B(+4.6%)
$309.25M(+6.9%)
$1.31B(-0.0%)
Sep 2021
-
$289.38M(-20.0%)
$1.31B(+1.7%)
Jun 2021
-
$361.81M(+2.4%)
$1.29B(+4.4%)
Mar 2021
-
$353.22M(+14.1%)
$1.24B(-1.2%)
Dec 2020
$1.26B(-1.4%)
$309.56M(+15.9%)
$1.25B(-2.0%)
Sep 2020
-
$267.10M(-13.2%)
$1.28B(-5.5%)
Jun 2020
-
$307.75M(-16.5%)
$1.35B(+1.1%)
Mar 2020
-
$368.69M(+9.8%)
$1.34B(+5.1%)
Dec 2019
$1.27B(+10.6%)
$335.74M(-1.7%)
$1.27B(+5.5%)
Sep 2019
-
$341.69M(+16.8%)
$1.21B(+3.6%)
Jun 2019
-
$292.66M(-3.5%)
$1.17B(+0.2%)
Mar 2019
-
$303.37M(+12.4%)
$1.16B(+1.1%)
Dec 2018
$1.15B(+10.6%)
$269.92M(-10.1%)
$1.15B(-0.4%)
Sep 2018
-
$300.19M(+3.4%)
$1.16B(+2.5%)
Jun 2018
-
$290.39M(-0.3%)
$1.13B(+3.5%)
Mar 2018
-
$291.16M(+6.2%)
$1.09B(+4.7%)
Dec 2017
$1.04B(+19.5%)
$274.20M(+0.9%)
$1.04B(+4.6%)
Sep 2017
-
$271.71M(+7.6%)
$995.28M(+5.5%)
Jun 2017
-
$252.42M(+4.0%)
$943.69M(+0.4%)
Mar 2017
-
$242.70M(+6.2%)
$940.37M(+6.8%)
Dec 2016
$870.92M(+22.8%)
$228.44M(+3.8%)
$880.60M(+6.2%)
Sep 2016
-
$220.12M(-11.6%)
$829.15M(+6.8%)
Jun 2016
-
$249.10M(+36.2%)
$776.00M(+6.0%)
Mar 2016
-
$182.93M(+3.4%)
$731.83M(+2.6%)
Dec 2015
$709.37M(+15.3%)
$176.99M(+6.0%)
$713.47M(-0.8%)
Sep 2015
-
$166.97M(-18.5%)
$719.55M(+3.1%)
Jun 2015
-
$204.94M(+24.5%)
$697.81M(+6.8%)
Mar 2015
-
$164.56M(-10.1%)
$653.19M(+6.0%)
Dec 2014
$615.30M(+36.9%)
$183.08M(+26.1%)
$616.25M(+12.7%)
Sep 2014
-
$145.23M(-9.4%)
$546.92M(+9.3%)
Jun 2014
-
$160.32M(+25.6%)
$500.27M(+12.9%)
Mar 2014
-
$127.62M(+12.2%)
$443.30M(+7.1%)
Dec 2013
$449.51M(+12.4%)
$113.76M(+15.4%)
$413.91M(+4.9%)
Sep 2013
-
$98.58M(-4.6%)
$394.64M(-1.0%)
Jun 2013
-
$103.34M(+5.2%)
$398.71M(+1.6%)
Mar 2013
-
$98.23M(+4.0%)
$392.46M(+0.6%)
Dec 2012
$399.86M(+22.3%)
$94.49M(-8.0%)
$390.20M(+4.6%)
Sep 2012
-
$102.66M(+5.7%)
$373.20M(+3.0%)
Jun 2012
-
$97.09M(+1.2%)
$362.46M(+1.3%)
Mar 2012
-
$95.97M(+23.9%)
$357.93M(+2.3%)
DateAnnualQuarterlyTTM
Dec 2011
$326.84M(+10.8%)
$77.48M(-15.7%)
$349.99M(-1.0%)
Sep 2011
-
$91.92M(-0.7%)
$353.45M(+4.5%)
Jun 2011
-
$92.56M(+5.2%)
$338.35M(+5.2%)
Mar 2011
-
$88.02M(+8.7%)
$321.76M(+6.8%)
Dec 2010
$294.89M(+15.2%)
$80.94M(+5.4%)
$301.27M(+1.9%)
Sep 2010
-
$76.82M(+1.1%)
$295.54M(+3.6%)
Jun 2010
-
$75.97M(+12.5%)
$285.25M(+5.5%)
Mar 2010
-
$67.54M(-10.2%)
$270.44M(+3.4%)
Dec 2009
$255.90M(+6.8%)
$75.21M(+13.1%)
$261.43M(-4.1%)
Sep 2009
-
$66.52M(+8.8%)
$272.73M(+3.4%)
Jun 2009
-
$61.16M(+4.5%)
$263.70M(+3.0%)
Mar 2009
-
$58.52M(-32.4%)
$256.02M(+6.8%)
Dec 2008
$239.61M(+142.4%)
$86.52M(+50.5%)
$239.61M(+25.0%)
Sep 2008
-
$57.49M(+7.5%)
$191.63M(+24.8%)
Jun 2008
-
$53.49M(+27.0%)
$153.59M(+24.5%)
Mar 2008
-
$42.12M(+9.3%)
$123.34M(+24.8%)
Dec 2007
$98.85M(+55.6%)
$38.54M(+98.1%)
$98.85M(+29.8%)
Sep 2007
-
$19.45M(-16.3%)
$76.16M(+2.2%)
Jun 2007
-
$23.23M(+31.8%)
$74.49M(+4.2%)
Mar 2007
-
$17.63M(+11.3%)
$71.52M(+12.7%)
Dec 2006
$63.51M(+389.9%)
$15.84M(-10.9%)
$63.44M(+17.2%)
Sep 2006
-
$17.79M(-12.2%)
$54.12M(+31.7%)
Jun 2006
-
$20.26M(+112.0%)
$41.09M(+87.9%)
Mar 2006
-
$9.55M(+46.6%)
$21.87M(+51.2%)
Dec 2005
$12.96M(+820.2%)
$6.52M(+36.7%)
$14.46M(-19.4%)
Sep 2005
-
$4.77M(+363.2%)
$17.94M(+152.3%)
Jun 2005
-
$1.03M(-52.1%)
$7.11M(+7.3%)
Mar 2005
-
$2.15M(-78.5%)
$6.63M(+48.0%)
Dec 2004
$1.41M(-114.9%)
$9.99M(-264.8%)
$4.48M(-181.2%)
Sep 2004
-
-$6.06M(-1206.2%)
-$5.51M(+131.3%)
Jun 2004
-
$548.00K(>+9900.0%)
-$2.38M(-18.7%)
Mar 2004
-
$0.00(0.0%)
-$2.93M(0.0%)
Dec 2003
-$9.44M(-274.4%)
$0.00(-100.0%)
-$2.93M(+30.8%)
Sep 2003
-
-$2.93M(<-9900.0%)
-$2.24M(-210.9%)
Jun 2003
-
$0.00(0.0%)
$2.02M(-41.8%)
Mar 2003
-
$0.00(-100.0%)
$3.48M(-35.8%)
Dec 2002
$5.42M(-2.0%)
$690.00K(-48.2%)
$5.42M(+14.6%)
Sep 2002
-
$1.33M(-8.5%)
$4.72M(-2.8%)
Jun 2002
-
$1.45M(-25.1%)
$4.86M(+11.0%)
Mar 2002
-
$1.94M(>+9900.0%)
$4.38M(-6.4%)
Dec 2001
$5.53M(-2.4%)
$0.00(-100.0%)
$4.68M(-22.6%)
Sep 2001
-
$1.47M(+50.8%)
$6.04M(+7.4%)
Jun 2001
-
$974.00K(-56.5%)
$5.63M(-9.9%)
Mar 2001
-
$2.24M(+64.2%)
$6.25M(+10.4%)
Dec 2000
$5.66M(+337.1%)
$1.36M(+29.4%)
$5.66M(+56.5%)
Sep 2000
-
$1.05M(-33.9%)
$3.62M(+15.5%)
Jun 2000
-
$1.59M(-3.5%)
$3.13M(+85.0%)
Mar 2000
-
$1.65M(-342.8%)
$1.69M(+380.6%)
Dec 1999
$1.29M(+157.2%)
-$680.00K(-219.8%)
$352.30K(-65.9%)
Sep 1999
-
$567.70K(+267.7%)
$1.03M(+122.2%)
Jun 1999
-
$154.40K(-50.2%)
$464.60K(+49.8%)
Mar 1999
-
$310.20K(>+9900.0%)
$310.20K(>+9900.0%)
Dec 1998
$503.50K(<-9900.0%)
-
-
Dec 1998
-
$0.00
$0.00
Dec 1997
-$4800.00
-
-

FAQ

  • What is BioMarin Pharmaceutical Inc. annual gross profit?
  • What is the all time high annual gross profit for BioMarin Pharmaceutical Inc.?
  • What is BioMarin Pharmaceutical Inc. annual gross profit year-on-year change?
  • What is BioMarin Pharmaceutical Inc. quarterly gross profit?
  • What is the all time high quarterly gross profit for BioMarin Pharmaceutical Inc.?
  • What is BioMarin Pharmaceutical Inc. quarterly gross profit year-on-year change?
  • What is BioMarin Pharmaceutical Inc. TTM gross profit?
  • What is the all time high TTM gross profit for BioMarin Pharmaceutical Inc.?
  • What is BioMarin Pharmaceutical Inc. TTM gross profit year-on-year change?

What is BioMarin Pharmaceutical Inc. annual gross profit?

The current annual gross profit of BMRN is $2.22B

What is the all time high annual gross profit for BioMarin Pharmaceutical Inc.?

BioMarin Pharmaceutical Inc. all-time high annual gross profit is $2.22B

What is BioMarin Pharmaceutical Inc. annual gross profit year-on-year change?

Over the past year, BMRN annual gross profit has changed by +$373.37M (+20.27%)

What is BioMarin Pharmaceutical Inc. quarterly gross profit?

The current quarterly gross profit of BMRN is $672.54M

What is the all time high quarterly gross profit for BioMarin Pharmaceutical Inc.?

BioMarin Pharmaceutical Inc. all-time high quarterly gross profit is $672.54M

What is BioMarin Pharmaceutical Inc. quarterly gross profit year-on-year change?

Over the past year, BMRN quarterly gross profit has changed by +$108.64M (+19.27%)

What is BioMarin Pharmaceutical Inc. TTM gross profit?

The current TTM gross profit of BMRN is $2.39B

What is the all time high TTM gross profit for BioMarin Pharmaceutical Inc.?

BioMarin Pharmaceutical Inc. all-time high TTM gross profit is $2.39B

What is BioMarin Pharmaceutical Inc. TTM gross profit year-on-year change?

Over the past year, BMRN TTM gross profit has changed by +$379.82M (+18.85%)
On this page